What to do if you have pelvic inflammatory bleeding

We all know that pelvic inflammatory disease is a relatively serious gynecological disease for women, because this gynecological disease not only causes dysmenorrhea in women, but also may make women feel bloated. In severe cases, the onset of inflammation may lead to repeated illness, thus causing female infertility. Especially for women in the pelvic inflammatory disease period, they must not get pregnant. So what should we do if pelvic inflammatory bleeding occurs?

What causes bleeding from pelvic inflammatory disease? Experts say that women usually experience such symptoms mainly because they continue to have sex after being infected with the inflammation. If they continue to have sex blindly after being infected with the inflammation, it may cause vaginal contact bleeding. It usually manifests as vaginal bleeding and leucorrhea with blood.

The main symptoms women experience when infected with pelvic inflammatory disease are lower abdominal pain, lumbar pain, etc. Some women may also experience symptoms such as increased vaginal discharge and irregular menstruation. Women may also experience bleeding symptoms after being infected with pelvic inflammatory disease.

After being infected with pelvic inflammatory disease, women should make sure to seek medical attention and treatment as soon as possible. Usually, women can treat pelvic inflammatory disease by choosing medication or surgery. Generally, if women are infected with acute pelvic inflammatory disease, they can choose to use medication for treatment, but if they are infected with chronic pelvic inflammatory disease, women should choose to use physical therapy for treatment, so that the treatment effect will be more obvious.

Pelvic inflammatory disease may cause vaginal bleeding in women, but it does not mean that vaginal bleeding is related to pelvic inflammatory disease. This is because bad hygiene habits, such as having sex during menstruation, within one month after delivery, taking a bath one month after gynecological surgery, artificial abortion, and induction of labor without strict disinfection, can cause nosocomial infection and can also cause pelvic effusion and vaginal bleeding. Pelvic inflammatory disease is a serious gynecological disease and must be treated promptly.

The treatment of pelvic inflammatory bleeding mainly involves the use of some anti-inflammatory antibiotics. Before using antibiotics, bacterial culture and drug sensitivity tests of vaginal secretions should be performed, and the most appropriate drug should be selected through drug sensitivity tests. It should be noted that the dosage must be large enough and the time must be long enough. Clinically, some patients stop taking the medicine after the symptoms disappear after a few days of use. This can easily cause recurrence and even lead to the occurrence of chronic pelvic inflammatory disease, so the treatment must be thorough.

It is common to use antibiotics to treat pelvic inflammatory bleeding, which can eliminate pathogens, improve symptoms and reduce sequelae. It is best to choose antimicrobial drugs based on the pathogen and the results of drug sensitivity tests, but because drug sensitivity results take 5-7 days, doctors often choose antibiotics based on experience when starting treatment. Since acute pelvic inflammatory disease is mostly a mixed infection of aerobic and anaerobic bacteria, broad-spectrum antibiotics mainly based on bactericides are often used in combination with anti-anaerobic drugs.

If chlamydia and mycoplasma are present, azithromycin should be added. Clindamycin combined with aminoglycosides is effective against infections mainly caused by anaerobic bacteria. The drug should be administered early, in sufficient amounts, and intravenously. Medication should not be changed frequently and the course of treatment should be long enough. Such as the combination of quinolones and metronidazole; the combination of penicillin or erythromycin with aminoglycosides and metronidazole; the commonly used regimens for Gram-negative bacilli and gonococci include second-generation cephalosporins and third-generation cephalosporins.